Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Erectile Dysfunction 8Prostatic Neoplasms 7Rectal Neoplasms 2Neoplasms 2Fatigue 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Solid Tumor 1Sexuality 1Sexual Dysfunction, Physiological 1Sarcoma 1Pre-Eclampsia 1Postoperative Complications 1Penile Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Mental Fatigue 1Lymphoma, Follicular 1Lymphatic Abnormalities 1Lymphangioma 1Infertility 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Erectile Dysfunction Following Radical Prostatectomy 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

mirdametinib 1Therapeutics 1Surgical Procedures, Operative 1Sildenafil Citrate 1Sclerotherapy 1Risk Factors 1Injections, Intralesional 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphatic Abnormalities × Sildenafil Citrate × Clear all
NCT01290484 2015-06-19

A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

Stanford University

Phase 1/2 Completed
7 enrolled 5 charts

Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡